Published on : Aug 01, 2016
ALBANY, New York, August 01, 2016: ResearchMoz.us has announced the inclusion of a new research report, titled “Global Stem Cell Therapies Industry 2016, Trends and Forecast Report,” to its vast repository of research studies. The 153-page report on the global stem cell therapies industry studies the current state of the market and determine how the overall industry will showcase its growth in the next few years. The research study looks into key market indicators, including the drivers, opportunities, and challenges that will influence the growth of this industry throughout the forecast period. The research study provides the growth analytics of the global stem cell therapies industry across North America, Asia, and Europe for the 2016-2020 period.
The research study has presented forecast figures and historical data of the global stem cell therapies industry with the assistance of tables, charts, infographics, and graphs. In addition, the research study offers a comprehensive view regarding the opportunities in the industry to guide the new players in allocating their investments in an effective manner.
Stem cell therapy makes use of stem cells to prevent or treat several diseases. The rising research and development activities in the medical sector have contributed extensively towards the growth of the global stem cell therapies industry. The research study has been classified on the basis of type and application, in which each segment has been discussed in detail to provide a clear picture of the overall industry.
Click here to get more info with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=756315
Governments and private organizations across the globe are offering funds for developing new stem cell lines. Moreover, the development of advanced genomic techniques for stem cell analysis is projected to fuel the growth of the overall industry in the next few years. In addition, the technological developments in this field are giving favorable results and are expected to cure some of the life-threatening diseases in the near future.
On the other hand, issues related to the preservation of stem cells, ethical concerns associated with acquiring embryonic stem cells, and the lack of necessary infrastructure are some of the prominent factors estimated to impede the growth of the industry in the forecast period. The lack of transparent regulatory guidelines, the need for automated cell culturing, and the dearth of reimbursement are some of the challenges faced by the leading players in this industry.
Furthermore, the research study throws light on the competitive landscape of the global stem cell therapies industry and offers a detailed analysis of the leading players in the overall industry. The company profiles, product specifications, financial status, and business overview of the prominent players in the industry have been discussed in the research report. Some of the key players engaged in the global stem cell therapies industry are Roslin Cells, International Stem Cell Corporation, Regeneus Ltd, Mesoblast Ltd., and ReNeuron Group plc.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org